Fate Therapeutics to Present at Biotech Showcase 2016
06 janv. 2016 16h01 HE
|
Fate Therapeutics, Inc.
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the...